<DOC>
	<DOCNO>NCT01456234</DOCNO>
	<brief_summary>The main purpose study see patient flu would receive oseltamivir treatment quickly prescribe pharmacist compare physician , see difference effect treatment flu symptom overall health . Another reason study see accurately pharmacist diagnose flu compare physician . Viruses expose antiviral medication ( like oseltamivir ) sometimes develop resistance medication . This mean medication longer effective treating symptom cause virus . The development viral resistance oseltamivir also follow study .</brief_summary>
	<brief_title>Time Oseltamivir Access When Prescribed Pharmacists Versus Physicians ( ACCESS )</brief_title>
	<detailed_description />
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>Inclusion Criteria Group 1 1 . Male female subject ≥ 18 year age present pharmacy current prescription oseltamivir ( 75 mg capsule BID 5 day per Canadian label ) treatment current influenza symptom 2 . Willingness undergo 2 nasal swab procedure 3 . Willingness participate study evidence write sign Informed Consent Form Inclusion Criteria Group 2 1 . Male female subject ≥ 18 year age present pharmacy indicative clinical symptoms/signs uncomplicated acute illness due influenza infection start within maximum 2 day prior visit pharmacy ( see Appendix A : FACTSS Influenza Diagnostic Tool ) 2 . Suitable oseltamivir treatment dose 75 mg BID ( see Appendix B : Algorithm Determining Suitability Pharmacist Prescribing Oseltamivir ) 3 . Willingness undergo 2 nasal swab procedure 4 . Willingness pay ( covered insurance ) receive treatment oseltamivir 5 . Willingness participate study evidence write sign Informed Consent Form Exclusion Criteria Group 1 1 . Subjects prescribe formulation ( i.e. , oral suspension ) dose regimen oseltamivir , antiviral medication treatment influenza 2 . Individuals present pharmacy oseltamivir prescription currently diagnosis influenza ( e.g. , individual fill prescription someone else currently infect influenza ; individual fill prescription someone else use prevention influenza infection treatment future influenza infection ) 3 . Subjects receive oseltamivir prescription physician participate study 4 . Subjects oseltamivir prescription fill reason 5 . Subjects , opinion research personnel , comply study procedures 6 . Staff pharmacy primary care clinic involve study , family member Exclusion Criteria Group 2 1 . Subjects already start treatment antiviral medication current influenza symptom 2 . Subjects oseltamivir prescription fill reason 3 . Subjects , opinion investigator , suitable study clinical reason ( e.g. , patient require hospitalisation able comply study procedure ) 4 . Staff pharmacy primary care clinic involve study , family member</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>